Cyclosporine is safe and effective in patients with severe ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 45, Issue 2, 2011, Pages 107-112

  Cheifetz, Adam S ^a   Stern, Joshua ^b   Garud, Sagar ^a   Goldstein, Eric ^b   Malter, Lisa ^b   Moss, Alan C ^a   Present, Daniel H ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cyclosporine; drug therapy; Inflammatory bowel disease; toxicity; ulcerative colitis

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GINGIVA HYPERPLASIA; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPERTRICHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; TREATMENT RESPONSE; ULCERATIVE COLITIS; UPPER RESPIRATORY TRACT INFECTION;

6-MERCAPTOPURINE; ADULT; COLECTOMY; COLITIS, ULCERATIVE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENGTH OF STAY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 78951493325     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181e883dd     Document Type: Article

References (28)

1. Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5:103-110.
2. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330:1841-1845.
3. Garcia-Lopez S, Gomollon-Garcia F, Perez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol. 2005;28:607-614.
4. Durai D, Hawthorne AB. Review article: how and when to use ciclosporin in ulcerative colitis. Aliment Pharmacol Ther. 2005; 22:907-916.
5. Shibolet O, Regushevskaya E, Brezis M, et al. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev. 2005;1:CD004277.
6. Campbell S, Travis SPL, Jewell DP. Cyclosprorin use in acute severe ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol. 2005;17:79-84.
7. Moskovitz DN, Van Assche G, Maenhout B, et al. Incidence of colectomy during long-term follow-up after cyclosporineinduced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol. 2006;4:760-765.
8. Actis GC, Fadda M, David E, et al. Colectomy rate in steroidrefractory colitis initially responsive to cyclosporin: a longterm retrospective cohort study. BMC Gastroenterol. 2007; 7:13.
9. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol. 1999;94:1587-1592.
10. Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis. 2004;10:73-78.
11. Sternthal M, Murphy S, George J, et al. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103: 937-943.
12. Kornbluth AA, Present DH, Lichtiger S. Cyclosporin for severe ulcerative colitis: a users guide. Am J Gastroenterol. 1997;92:1424-1428.
13. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis. 1999;5:1-10.
14. Van Assche G, D'Haens G, Noman M, et al. Randomised, double blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterolgy. 2003;125:1025-1031.
15. D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001;120:1323-1329.
16. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomised, placebo-controlled study. Gastroenterology. 2005; 128:1805-1811.
17. Probert CS, Hearing SD, Schreiber S, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut. 2003;52:998-1002.
18. Gusttavsson A, Jarnerot G, Hertervig E. A 2-year follow up study of the Swedish-Danish infliximab trial in steroid resistant acute ulcerative colitis. Gastroenterology. 2007;132(supp 2): Abstract 983:p146.
19. Kohn A, Daperno M, Armuzzi A, et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther. 2007;26:747-756.
20. Jakobovits SL, Jewell DP, Travis SP. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther. 2007;25:1055-1060.
21. Columbel JF, Loftus EV, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohns disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004;126: 19-31.
22. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohns disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4:621-630.
23. Hahnloser D, Pemberton JH, Wolff BG, et al. Results at up to 20 years after ileal-pouch-anal anastomosis for chronic ulcerative colitis. British J Surg. 2007;94:333-340.
24. Meagher AP, Farouk R, Dozois RR, et al. Jileal pouch-anal anastomosis for chronic ulcerative colitis: complications and longterm outcome in 1310 patients. British J Surg. 1998;85:800-803.
25. Pemberton JH, Kelly KA, Beart RW Jr, et al. Ileal pouch-anal anastomosis for chronic ulcerative colitis: long-term results. Ann Surg. 1987;206:504-513.
26. Mahadevan U, Sandborn S. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636-1650.
27. Stocchi L, Pemberton JH. Pouch and pouchitis. Gastro Clin NA. 2001;30:223-241.
28. Waljee A, Waljee J, Morris A, et al. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575-1580.